Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis

Published:2024-04 Issue:4 Volume:17 Page:632-641
ISSN:1876-0341
Container-title:Journal of Infection and Public Health
language:en
Short-container-title:Journal of Infection and Public Health

Author:

Zhang Fuzhen,Zhang Fan,Li Liang,Pang Yu^ORCID

Publisher

Elsevier BV

Reference49 articles.

1. Global tuberculosis report 2022;WHO,2022

2. Global tuberculosis report 2020 - reflections on the global TB burden, treatment and prevention efforts;Chakaya;Int J Infect Dis,2021

3. Multi-Drug resistant and extensively-drug resistant tuberculosis;Shah;Indian J Pediatr,2020

4. Adverse drug reactions & drug interactions in MDR-TB patients;Gupta;Indian J Tuberc,2020

5. Adverse drug reactions in tuberculosis and management;Prasad;Indian J Tuberc,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence in tuberculosis diagnosis: Revolutionizing detection and treatment;IP Indian Journal of Immunology and Respiratory Medicine;2024-07-15

2. Advancements in Artificial Intelligence for the Diagnosis of Multidrug Resistance and Extensively Drug-Resistant Tuberculosis: A Comprehensive Review;Cureus;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP